PF-07985045
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07985045, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. [Phase 1]